Copyright Reports & Markets. All rights reserved.

Global Propofol Medium/Long Chain Fat Emulsion Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Propofol Medium/Long Chain Fat Emulsion Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 10 mL
    • 1.3.3 20 mL
    • 1.3.4 50 mL
    • 1.3.5 100 mL
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Propofol Medium/Long Chain Fat Emulsion Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Other
  • 1.5 Global Propofol Medium/Long Chain Fat Emulsion Injection Market Size & Forecast
    • 1.5.1 Global Propofol Medium/Long Chain Fat Emulsion Injection Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Quantity (2021-2032)
    • 1.5.3 Global Propofol Medium/Long Chain Fat Emulsion Injection Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Fresenius Kabi
    • 2.1.1 Fresenius Kabi Details
    • 2.1.2 Fresenius Kabi Major Business
    • 2.1.3 Fresenius Kabi Propofol Medium/Long Chain Fat Emulsion Injection Product and Services
    • 2.1.4 Fresenius Kabi Propofol Medium/Long Chain Fat Emulsion Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Fresenius Kabi Recent Developments/Updates
  • 2.2 B. Braun
    • 2.2.1 B. Braun Details
    • 2.2.2 B. Braun Major Business
    • 2.2.3 B. Braun Propofol Medium/Long Chain Fat Emulsion Injection Product and Services
    • 2.2.4 B. Braun Propofol Medium/Long Chain Fat Emulsion Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 B. Braun Recent Developments/Updates
  • 2.3 Guangdong Jiabo Pharmaceutical
    • 2.3.1 Guangdong Jiabo Pharmaceutical Details
    • 2.3.2 Guangdong Jiabo Pharmaceutical Major Business
    • 2.3.3 Guangdong Jiabo Pharmaceutical Propofol Medium/Long Chain Fat Emulsion Injection Product and Services
    • 2.3.4 Guangdong Jiabo Pharmaceutical Propofol Medium/Long Chain Fat Emulsion Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Guangdong Jiabo Pharmaceutical Recent Developments/Updates
  • 2.4 Sichuan Biokin Pharmaceutical
    • 2.4.1 Sichuan Biokin Pharmaceutical Details
    • 2.4.2 Sichuan Biokin Pharmaceutical Major Business
    • 2.4.3 Sichuan Biokin Pharmaceutical Propofol Medium/Long Chain Fat Emulsion Injection Product and Services
    • 2.4.4 Sichuan Biokin Pharmaceutical Propofol Medium/Long Chain Fat Emulsion Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Sichuan Biokin Pharmaceutical Recent Developments/Updates
  • 2.5 Sichuan Kelun Pharmaceutical
    • 2.5.1 Sichuan Kelun Pharmaceutical Details
    • 2.5.2 Sichuan Kelun Pharmaceutical Major Business
    • 2.5.3 Sichuan Kelun Pharmaceutical Propofol Medium/Long Chain Fat Emulsion Injection Product and Services
    • 2.5.4 Sichuan Kelun Pharmaceutical Propofol Medium/Long Chain Fat Emulsion Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Sichuan Kelun Pharmaceutical Recent Developments/Updates
  • 2.6 Jiangsu Yingke Biopharmaceutical
    • 2.6.1 Jiangsu Yingke Biopharmaceutical Details
    • 2.6.2 Jiangsu Yingke Biopharmaceutical Major Business
    • 2.6.3 Jiangsu Yingke Biopharmaceutical Propofol Medium/Long Chain Fat Emulsion Injection Product and Services
    • 2.6.4 Jiangsu Yingke Biopharmaceutical Propofol Medium/Long Chain Fat Emulsion Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Jiangsu Yingke Biopharmaceutical Recent Developments/Updates

3 Competitive Environment: Propofol Medium/Long Chain Fat Emulsion Injection by Manufacturer

  • 3.1 Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Manufacturer (2021-2026)
  • 3.3 Global Propofol Medium/Long Chain Fat Emulsion Injection Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Propofol Medium/Long Chain Fat Emulsion Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Propofol Medium/Long Chain Fat Emulsion Injection Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Propofol Medium/Long Chain Fat Emulsion Injection Manufacturer Market Share in 2025
  • 3.5 Propofol Medium/Long Chain Fat Emulsion Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Propofol Medium/Long Chain Fat Emulsion Injection Market: Region Footprint
    • 3.5.2 Propofol Medium/Long Chain Fat Emulsion Injection Market: Company Product Type Footprint
    • 3.5.3 Propofol Medium/Long Chain Fat Emulsion Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Propofol Medium/Long Chain Fat Emulsion Injection Market Size by Region
    • 4.1.1 Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Propofol Medium/Long Chain Fat Emulsion Injection Consumption Value by Region (2021-2032)
    • 4.1.3 Global Propofol Medium/Long Chain Fat Emulsion Injection Average Price by Region (2021-2032)
  • 4.2 North America Propofol Medium/Long Chain Fat Emulsion Injection Consumption Value (2021-2032)
  • 4.3 Europe Propofol Medium/Long Chain Fat Emulsion Injection Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Propofol Medium/Long Chain Fat Emulsion Injection Consumption Value (2021-2032)
  • 4.5 South America Propofol Medium/Long Chain Fat Emulsion Injection Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Propofol Medium/Long Chain Fat Emulsion Injection Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Quantity by Type (2021-2032)
  • 5.2 Global Propofol Medium/Long Chain Fat Emulsion Injection Consumption Value by Type (2021-2032)
  • 5.3 Global Propofol Medium/Long Chain Fat Emulsion Injection Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Quantity by Application (2021-2032)
  • 6.2 Global Propofol Medium/Long Chain Fat Emulsion Injection Consumption Value by Application (2021-2032)
  • 6.3 Global Propofol Medium/Long Chain Fat Emulsion Injection Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Propofol Medium/Long Chain Fat Emulsion Injection Sales Quantity by Type (2021-2032)
  • 7.2 North America Propofol Medium/Long Chain Fat Emulsion Injection Sales Quantity by Application (2021-2032)
  • 7.3 North America Propofol Medium/Long Chain Fat Emulsion Injection Market Size by Country
    • 7.3.1 North America Propofol Medium/Long Chain Fat Emulsion Injection Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Propofol Medium/Long Chain Fat Emulsion Injection Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Propofol Medium/Long Chain Fat Emulsion Injection Sales Quantity by Type (2021-2032)
  • 8.2 Europe Propofol Medium/Long Chain Fat Emulsion Injection Sales Quantity by Application (2021-2032)
  • 8.3 Europe Propofol Medium/Long Chain Fat Emulsion Injection Market Size by Country
    • 8.3.1 Europe Propofol Medium/Long Chain Fat Emulsion Injection Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Propofol Medium/Long Chain Fat Emulsion Injection Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Propofol Medium/Long Chain Fat Emulsion Injection Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Propofol Medium/Long Chain Fat Emulsion Injection Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Propofol Medium/Long Chain Fat Emulsion Injection Market Size by Region
    • 9.3.1 Asia-Pacific Propofol Medium/Long Chain Fat Emulsion Injection Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Propofol Medium/Long Chain Fat Emulsion Injection Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Propofol Medium/Long Chain Fat Emulsion Injection Sales Quantity by Type (2021-2032)
  • 10.2 South America Propofol Medium/Long Chain Fat Emulsion Injection Sales Quantity by Application (2021-2032)
  • 10.3 South America Propofol Medium/Long Chain Fat Emulsion Injection Market Size by Country
    • 10.3.1 South America Propofol Medium/Long Chain Fat Emulsion Injection Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Propofol Medium/Long Chain Fat Emulsion Injection Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Propofol Medium/Long Chain Fat Emulsion Injection Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Propofol Medium/Long Chain Fat Emulsion Injection Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Propofol Medium/Long Chain Fat Emulsion Injection Market Size by Country
    • 11.3.1 Middle East & Africa Propofol Medium/Long Chain Fat Emulsion Injection Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Propofol Medium/Long Chain Fat Emulsion Injection Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Propofol Medium/Long Chain Fat Emulsion Injection Market Drivers
  • 12.2 Propofol Medium/Long Chain Fat Emulsion Injection Market Restraints
  • 12.3 Propofol Medium/Long Chain Fat Emulsion Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Propofol Medium/Long Chain Fat Emulsion Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Propofol Medium/Long Chain Fat Emulsion Injection
  • 13.3 Propofol Medium/Long Chain Fat Emulsion Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Propofol Medium/Long Chain Fat Emulsion Injection Typical Distributors
  • 14.3 Propofol Medium/Long Chain Fat Emulsion Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Propofol Medium/Long Chain Fat Emulsion Injection market size was valued at US$ 415 million in 2025 and is forecast to a readjusted size of US$ 530 million by 2032 with a CAGR of 3.6% during review period.
    In 2024, global propofol medium/long chain fat emulsion injection production reached approximately 21.65 million units, with an average global market price of around US$ 18 per unit. Propofol is a short-acting, intravenous anesthetic agent used for the induction and maintenance of general anesthesia, sedation for mechanically ventilated adults, and procedural sedation. Propofol has the advantages of fast onset of anesthesia induction, rapid awakening, perfect functional recovery, and low incidence of adverse reactions such as postoperative nausea and vomiting. Propofol medium/long chain fat emulsion injection is an oil-in-water emulsion formulation of propofol, in which the lipid vehicle consists of a mixture of medium-chain triglycerides (MCT) and long-chain triglycerides (LCT), along with an emulsifier (egg lecithin) and glycerol. Its gross profit margin generally ranges from 50% to 80%.
    Increasing Demand:
    The demand for propofol is increasing, driven by the rising incidence of chronic diseases, surgeries, and medical procedures. The aging population, changing lifestyles, and growing healthcare infrastructure in emerging markets are also contributing to the increasing demand for propofol.
    Technological Advancements:
    Advances in drug delivery systems and monitoring technologies are enhancing the use of propofol. Innovations such as target-controlled infusion (TCI) systems allow for more precise administration, improving safety and efficacy.
    Expanding Applications:
    Beyond traditional surgical and diagnostic procedures, propofol’s applications are expanding into areas such as pediatric anesthesia, veterinary medicine, and even in treating certain psychiatric disorders like refractory depression through off-label use.
    Intensified Competition:
    Competition among manufacturers will intensify further in the coming years. In addition, propofol substitutes will try to occupy more market share.
    This report is a detailed and comprehensive analysis for global Propofol Medium/Long Chain Fat Emulsion Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Propofol Medium/Long Chain Fat Emulsion Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Propofol Medium/Long Chain Fat Emulsion Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Propofol Medium/Long Chain Fat Emulsion Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Propofol Medium/Long Chain Fat Emulsion Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Propofol Medium/Long Chain Fat Emulsion Injection
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Propofol Medium/Long Chain Fat Emulsion Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fresenius Kabi, B. Braun, Guangdong Jiabo Pharmaceutical, Sichuan Biokin Pharmaceutical, Sichuan Kelun Pharmaceutical, Jiangsu Yingke Biopharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Propofol Medium/Long Chain Fat Emulsion Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    10 mL
    20 mL
    50 mL
    100 mL
    Market segment by Application
    Hospital
    Clinic
    Other
    Major players covered
    Fresenius Kabi
    B. Braun
    Guangdong Jiabo Pharmaceutical
    Sichuan Biokin Pharmaceutical
    Sichuan Kelun Pharmaceutical
    Jiangsu Yingke Biopharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Propofol Medium/Long Chain Fat Emulsion Injection product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Propofol Medium/Long Chain Fat Emulsion Injection, with price, sales quantity, revenue, and global market share of Propofol Medium/Long Chain Fat Emulsion Injection from 2021 to 2026.
    Chapter 3, the Propofol Medium/Long Chain Fat Emulsion Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Propofol Medium/Long Chain Fat Emulsion Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Propofol Medium/Long Chain Fat Emulsion Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Propofol Medium/Long Chain Fat Emulsion Injection.
    Chapter 14 and 15, to describe Propofol Medium/Long Chain Fat Emulsion Injection sales channel, distributors, customers, research findings and conclusion.

    Buy now